The European Medicines Agency is working with vaccine companies on the development of variant-adapted COVID-19 vaccines and says it expects the first ones to be approved by the autumn.
It is also working with industry on the development of second-generation vaccines with broader and more durable protection, but these...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?